Literature DB >> 20376064

Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.

Michela Perego1, Monica Tortoreto, Gabrina Tragni, Luigi Mariani, Paola Deho, Antonino Carbone, Mario Santinami, Roberto Patuzzo, Pamela Della Mina, Antonello Villa, Graziella Pratesi, Giacomo Cossa, Paola Perego, Maria G Daidone, Malcolm R Alison, Giorgio Parmiani, Licia Rivoltini, Chiara Castelli.   

Abstract

Melanospheres, the melanoma cells that grow as nonadherent colonies and that show in vitro self-renewing capacity and multipotency, were selected from melanoma specimens or from melanoma cell lines. Melanospheres were highly tumorigenic, and intradermal injections in severe combined immunodeficient (SCID) mice of as few as 100 cells generated tumors that maintained tumorigenic potential into subsequent recipients. Primary and serially transplanted xenografts recapitulated the phenotypic features of the original melanoma of the patient. Melanoma cells cultured in the presence of fetal calf serum (FCS) were also tumorigenic in SCID mice, although with lower efficiency; these xenografts showed a homogeneous phenotype for the expression of melanoma-associated markers, Melan-A/Mart-1, HMB45, and MITF, and contained cells with features of fully differentiated cells. Melanospheres were heterogeneous for the expression of stem cell markers and showed a significantly enhanced expression of the Nanog and Oct3/4 transcription factors when compared with adherent melanoma cells. No direct and unique correlation between any of the examined stem cell markers and in vivo tumorigenicity was found. Taken together, our data provide further evidence on the heterogeneous nature of human melanomas and show that melanospheres and their corresponding tumors, which are generated in vivo in immunocompromised mice, represent a model to investigate melanoma biology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376064     DOI: 10.1038/jid.2010.69

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  42 in total

1.  Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma.

Authors:  J Humberto Treviño-Villarreal; Douglas A Cotanche; Rosalinda Sepúlveda; Magda E Bortoni; Otto Manneberg; Taturo Udagawa; Rick A Rogers
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

2.  Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.

Authors:  Aurelie Borrull; Stephanie Ghislin; Frederique Deshayes; Jessica Lauriol; Catherine Alcaide-Loridan; Sandrine Middendorp
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-11       Impact factor: 4.553

3.  Heme oxygenase promotes B-Raf-dependent melanosphere formation.

Authors:  Kimberly J Jasmer; Jie Hou; Philip Mannino; Jianlin Cheng; Mark Hannink
Journal:  Pigment Cell Melanoma Res       Date:  2020-07-09       Impact factor: 4.693

Review 4.  The oncolytic virus ΔPK has multimodal anti-tumor activity.

Authors:  Laure Aurelian; Dominique Bollino; Aric Colunga
Journal:  Pathog Dis       Date:  2016-05-29       Impact factor: 3.166

Review 5.  Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?

Authors:  Constance E Brinckerhoff
Journal:  J Cell Physiol       Date:  2017-03-06       Impact factor: 6.384

6.  Clonogenic cell subpopulations maintain congenital melanocytic nevi.

Authors:  Christelle Charbel; Romain H Fontaine; Natacha Kadlub; Aurore Coulomb-L'Hermine; Thomas Rouillé; Alexandre How-Kit; Philippe Moguelet; Jorg Tost; Arnaud Picard; Selim Aractingi; Sarah Guégan
Journal:  J Invest Dermatol       Date:  2014-10-13       Impact factor: 8.551

7.  PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

Authors:  J Delyon; A Servy; F Laugier; J André; N Ortonne; M Battistella; S Mourah; A Bensussan; C Lebbé; N Dumaz
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

8.  The in vitro spheroid melanoma cell culture assay: cues on tumor initiation?

Authors:  Tobias Schatton; Markus H Frank
Journal:  J Invest Dermatol       Date:  2010-07       Impact factor: 8.551

9.  Honokiol inhibits melanoma stem cells by targeting notch signaling.

Authors:  Gaurav Kaushik; Anand Venugopal; Prabhu Ramamoorthy; David Standing; Dharmalingam Subramaniam; Shahid Umar; Roy A Jensen; Shrikant Anant; Joshua M V Mammen
Journal:  Mol Carcinog       Date:  2014-12-09       Impact factor: 4.784

10.  Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma.

Authors:  Walburga Croteau; Molly H Jenkins; Siying Ye; David W Mullins; Constance E Brinckerhoff
Journal:  J Cell Physiol       Date:  2013-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.